Phase 1b/2 Study of Carfilzomib, Carboplatin, and Etoposide in Patients With Previously Untreated Extensive Stage Small-cell Lung Cancer
Clinical trial NCT01987232 · COMPLETED
Trial details
- NCT number
- NCT01987232
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-05
- Primary completion
- 2016-08-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.